Figure 1
From: Polycomb-mediated silencing in neuroendocrine prostate cancer
Differential expression of epigenetic regulators in NEPC. Average fold change of individual EpRs grouped by distinct (A) epigenetic modifications, (B) epigenetic activities, and (C) transcriptional effects in clinical NEPC/PCa and the 331R/331 model. (D) Expression correlation of 22 EpRs upregulated by more than 1.5-fold in clinical NEPC/PCa and the 331R/331 model. (E) Expression levels of individual upregulated EpRs in clinical NEPC/PCa and the 331R/331 model.